A readily achievable initial approach is to confirm the existence of T cells expressing both CD137 and Eomes and/or FoxP3 + within the HPV + OSC microenvironment using in situ analysis of tumor tissue using immunofluorescence (IF) or immunohistochemistry (IHC). Here, TNFRSF9 is linked to neoplasm.